We are live on ! Find out more
OACCW

Oaktree Acquisition Corp III Life Sciences Warrant
OACCW

11 hedge funds and large institutions have $942K invested in Oaktree Acquisition Corp III Life Sciences Warrant in 2024 Q4 according to their latest regulatory filings, with 11 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
11
Holders Change
+11
Holders Change %
–
% of All Funds
0.14%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AA
AQR Arbitrage
Connecticut
+$259K
2
SCM
Shaolin Capital Management
Florida
+$87.6K
3
Walleye Capital
Walleye Capital
New York
+$75.6K
4
ECM
ExodusPoint Capital Management
New York
+$39.2K
5
TCM
Tenor Capital Management
New York
+$39.2K

Top Sellers

No sellers this quarter

OACCW Hedge Fund Activity: Q4 2024 in Review

11 of the 7,607 institutional investors tracked by Wall St. Rank reported a position in Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) for Q4 2024, worth a combined $942K.

Buyers outnumbered sellers: 11 funds opened new OACCW positions and 0 closed out — a net gain of 11 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was AQR Arbitrage, opening a new position worth an estimated $259K.

  • 11 institutional investors held Oaktree Acquisition Corp III Life Sciences Warrant (OACCW) as of Q4 2024, up from 0 in Q3 2024.
  • Funds reported $942K of Oaktree Acquisition Corp III Life Sciences Warrant stock for Q4 2024.
  • 11 funds opened new Oaktree Acquisition Corp III Life Sciences Warrant positions in Q4 2024 and 0 closed out, a net change of +11 holders.
  • The largest Oaktree Acquisition Corp III Life Sciences Warrant buyer in Q4 2024 was AQR Arbitrage, an estimated $259K added.

Based on aggregated 13F filings for Q4 2024.